Boldly transforming the lives of individuals with rare neurological diseases
Science-driven and patient-focused, our mission is to bring treatments to individuals with rare neurological diseases who have little or no treatment options.
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for rare neurological diseases.
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
- Ovid Therapeutics Launches Pipeline Teach-In Webinar Series
- Ovid Therapeutics Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference
- Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
- Ovid Therapeutics Announces Positive Topline Results from the Phase 2 ROCKET Trial of OV101 for the Treatment of Fragile X Syndrome